查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1532229

微针给药系统市场：全球产业分析、规模、占有率、成长、趋势、预测，2024-2033

Microneedle Drug Delivery Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research发布了有关全球微针给药系统市场的详细研究报告。本报告详细分析了主要市场动态，包括市场驱动因素、趋势、机会和挑战，并提供了对市场结构的全面见解。

关键见解

  • 微针给药系统市场规模（2024年）：67亿美元
  • 预估市值（2033年）：108亿美元
  • 全球市场成长率（2024年至2033年年复合成长率）：5.4%

微针给药系统市场-研究范围：

微针药物输送系统市场包括各种目的是使用微针透过皮肤无痛且有效地输送药物的技术。这个市场包括实心微针、空心微针、溶解微针等多种类型的微针装置，它们在透皮给药和疫苗接种方面发挥着重要作用。该市场服务于多种行业，包括药品、化妆品和诊断，并透过零售店、医院和诊所进行分销。消费者对微创给药方法的兴趣增加、无痛给药意识的增强以及自我给药趋势的成长推动了给药的成长。

推动市场成长的因素：

推动全球微针给药系统市场的关键因素有几个。慢性病的增加和对有效药物输送系统的需求推动对微针技术的需求。微针设计和材料的技术进步提高性能和可靠性，刺激市场扩张。此外，自我药疗和家庭保健的不断成长趋势推动对使用者友善和非侵入性给药系统的需求。可支配收入的增加和对优质医疗保健解决方案的关注也有助于市场扩张。

市场限制因素：

儘管成长前景广阔，但微针给药系统市场面临先进微针系统的高成本和原材料价格波动的挑战。它们还受到监管障碍和持续创新以满足不断变化的消费者偏好的需求的影响。此外，市场受到大量本地和无组织公司的影响，这些公司提供价格较低的替代品，这可能会限制现有品牌的市场占有率。解决这些问题并保持竞争力需要有效的供应链管理、有竞争力的定价以及持续的研发投资。

市场机会：

个人化医疗和药物输送的不断成长趋势为该市场带来了巨大的机会。高效、环保的微针系统的开发是为了满足对永续和先进医疗技术不断成长的需求。电子商务平台的扩张为市场成长提供了新的管道，使企业能够接触到更多的人。不断发展的城市化和越来越多具有健康意识的消费者推动对高品质微针系统的需求。战略合作伙伴关係、新技术投资以及创新药物输送解决方案的引进对于利用新机会和维持市场领先地位非常重要。

本报告涵盖的主要问题

  • 推动微针给药系统市场成长的关键因素是什么？
  • 哪些类型的微针和应用领域引领微针给药系统的采用？
  • 技术进步如何影响微针给药系统市场的竞争格局？
  • 谁是微针给药系统市场的主要参与者？ 他们采取什么策略来保持竞争力？
  • 全球微针给药系统市场的新趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场风险与趋势评估

  • 风险评估
    • COVID-19 危机及其对微针给药系统市场的影响
    • 与过去的危机相比，新冠肺炎（COVID-19）影响基准
    • 对市场价值的影响（金额）
    • 主要国家的评价
    • 依主要细分市场进行评估
    • 针对供应商的行动要点和建议
  • 影响市场的主要趋势
  • 配方和产品开发的趋势

第4章 市场背景

  • 主要国家微针给药系统市场
  • 微针给药系统市场机会评估（金额）
  • 市场情境预测
  • 投资可行性分析
  • 预测因子 - 相关性和影响
  • 市场动态

第5章 关键成功因素

  • 製造商致力于渗透率低但成长率高的市场
  • 押注该细分市场的高增量机会
  • 同业基准

第6章 全球市场需求分析

  • 2019-2023年市场分析
  • 2024-2033年市场预测
  • 年成长趋势分析

第7章 世界市值分析

  • 2019-2023年市场分析（金额）
  • 2024-2033年市场预测（金额）
    • 年成长趋势分析
    • 绝对的获利机会

第8章 依类型：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模分析（金额）
  • 2024-2033年市场规模分析与预测（金额）
    • 固体
    • 中空
    • 溶解
    • 涂层
    • 其他
  • 市场吸引力分析

第9章 依材料：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模分析（金额）
  • 2024-2033年市场规模分析与预测（金额）
    • 硅
    • 金属
    • 聚合物
    • 其他
  • 市场吸引力分析

第10章 依应用：世界市场分析

  • 简介/主要发现
  • 2019-2023年市场规模分析（金额）
  • 2024-2033年市场规模分析与预测（金额）
    • 皮肤科
    • 药物输送
    • 疼痛管理
    • 癌症治疗
    • 疫苗递送
    • 其他
  • 市场吸引力分析

第11章 依区域：市场分析

  • 简介
  • 2019-2023年市场规模分析（金额）
  • 2024-2033年市场规模分析与预测（金额）
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东和非洲（中东、非洲）
  • 市场吸引力分析

第12章 北美微针给药系统市场分析

第13章 拉丁美洲微针给药系统市场分析

第14章 欧洲微针给药系统市场分析

第15章 亚太地区微针给药系统市场分析

第16章 中东与非洲微针给药系统市场分析

第17章 主要国家微针给药系统市场分析

  • 简介
    • 主要国家市值比例分析
    • 世界与国家成长比较
  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 德国
  • 法国
  • 义大利
  • 印度
  • 英国
  • 澳洲
  • 中国
  • 日本
  • 韩国
  • 以色列
  • 南非
  • 阿联酋
  • 西班牙
  • 俄罗斯
  • 沙乌地阿拉伯
  • 国内竞争情势及参与者集中度

第18章 市场结构分析

  • 依公司层级的市场分析
  • 市场集中度
  • 主要公司市占率分析
  • 市场现况分析

第19章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详情
    • Raphas Co. Ltd.
    • Becton Dickinson and Company
    • NanoPass Technologies Limited
    • 3M
    • Zosano Pharma Corporation
    • Corium International Inc.
    • Valeritas Inc.
    • Nitto Denko Corporation
    • Microdermics Inc.
    • TheraJect Inc.
    • Vaxxas Pty Ltd.
    • Endoderma Ltd.
    • QuadMedicine
    • SNvia Co. Ltd.
    • Small Lab

第20章 使用的先决条件与缩写

第21章 研究方法

简介目录
Product Code: PMRREP33284

Persistence Market Research has recently published a detailed report on the global Microneedle Drug Delivery Systems market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

  • Microneedle Drug Delivery Systems Market Size (2024E): USD 6.7 Bn
  • Projected Market Value (2033F): USD 10.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Microneedle Drug Delivery Systems Market - Report Scope:

The Microneedle Drug Delivery Systems market encompasses a range of technologies designed to deliver drugs painlessly and effectively through the skin using microneedles. This market includes various types of microneedle devices such as solid microneedles, hollow microneedles, and dissolving microneedles, which are crucial for transdermal drug delivery and vaccination. The market serves different segments, including pharmaceuticals, cosmetics, and diagnostics, distributed through retail, hospitals, and clinics. Growth is driven by increasing consumer interest in minimally invasive drug delivery methods, rising awareness about pain-free administration, and the growing trend of self-administration of drugs.

Market Growth Drivers:

Several key factors drive the global Microneedle Drug Delivery Systems market. The rising prevalence of chronic diseases and the need for effective drug delivery systems boost demand for microneedle technologies. Technological advancements in microneedle design and materials enhance performance and reliability, fueling market expansion. Additionally, the growing trend of self-medication and home healthcare drives the demand for user-friendly and non-invasive drug delivery systems. Increased disposable income and a focus on premium healthcare solutions also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Microneedle Drug Delivery Systems market faces challenges related to the high cost of advanced microneedle systems and fluctuating raw material prices. The market is also impacted by regulatory hurdles and the need for continuous innovation to meet evolving consumer preferences. Furthermore, the market is influenced by the presence of numerous local and unorganized players offering lower-cost alternatives, which can limit market share for established brands. Effective supply chain management, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of personalized medicine and targeted drug delivery. The development of high-efficiency and eco-friendly microneedle systems caters to the growing demand for sustainable and advanced healthcare technologies. The expansion of e-commerce platforms provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious consumers drive the demand for high-quality microneedle systems. Strategic partnerships, investments in new technologies, and the introduction of innovative drug delivery solutions are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Microneedle Drug Delivery Systems market globally?
  • Which microneedle types and application areas are leading the adoption of microneedle drug delivery systems?
  • How are technological advancements influencing the competitive landscape of the Microneedle Drug Delivery Systems market?
  • Who are the key players in the Microneedle Drug Delivery Systems market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Microneedle Drug Delivery Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Microneedle Drug Delivery Systems market, including 3M, Becton Dickinson and Company, and Zosano Pharma Corporation, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced microneedle technologies, such as dissolvable microneedles and integrated microneedle patches. Collaborations with pharmaceutical companies, research institutions, and online platforms facilitate market access and promote new product adoption. Emphasis on sustainable manufacturing processes, high-performance materials, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Microneedle Drug Delivery Systems landscape.

Key Companies Profiled:

  • Raphas Co. Ltd.
  • Becton Dickinson and Company
  • NanoPass Technologies Limited
  • 3M
  • Zosano Pharma Corporation
  • Corium International Inc.
  • Valeritas Inc.
  • Nitto Denko Corporation
  • Microdermics Inc.
  • TheraJect Inc.
  • Vaxxas Pty Ltd.
  • Endoderma Ltd.
  • QuadMedicine
  • SNvia Co. Ltd.
  • Small Lab

Microneedle Drug Delivery Systems Market Industry Segmentation

By Type

  • Solid
  • Hollow
  • Dissolving
  • Coated
  • Other Types

By Material

  • Silicon
  • Metal
  • Polymer
  • Other Materials

By Application

  • Dermatology
  • Drug Delivery
  • Pain Management
  • Cancer Therapy
  • Vaccine Delivery
  • Other Applications

By Region

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on Microneedle Drug Delivery Systems Market
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Bn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background

  • 4.1. Microneedle Drug Delivery Systems Market, by Key Countries
  • 4.2. Microneedle Drug Delivery Systems Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Growth in Automation, By Country
    • 4.5.3. Microneedle Drug Delivery Systems Markets Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Microneedle Drug Delivery Systems Markets Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Microneedle Drug Delivery Systems Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Microneedle Drug Delivery Systems Market Value Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type, 2024-2033
    • 8.3.1. Solid
    • 8.3.2. Hollow
    • 8.3.3. Dissolving
    • 8.3.4. Coated
    • 8.3.5. Other Types
  • 8.4. Market Attractiveness Analysis By Microneedle Drug Delivery Systems

9. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Material

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Material, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Material, 2024-2033
    • 9.3.1. Silicon
    • 9.3.2. Metal
    • 9.3.3. Polymer
    • 9.3.4. Other Materiales
  • 9.4. Market Attractiveness Analysis By Application

10. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 10.3.1. Dermatology
    • 10.3.2. Drug Delivery
    • 10.3.3. Pain Management
    • 10.3.4. Cancer Therapy
    • 10.3.5. Vaccine Delivery
    • 10.3.6. Other Applications
  • 10.4. Market Attractiveness Analysis By Application

11. Global Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. Asia Pacific
    • 11.3.5. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis By Region

12. North America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. U.S.
      • 12.4.1.2. Canada
    • 12.4.2. By Type
    • 12.4.3. By Application
    • 12.4.4. By Application
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Material
    • 12.5.3. By Application
    • 12.5.4. By Application

13. Latin America Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Brazil
      • 13.4.1.2. Mexico
      • 13.4.1.3. Rest of Latin America
    • 13.4.2. By Type
    • 13.4.3. By Application
    • 13.4.4. By Application
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Material
    • 13.5.3. By Application
    • 13.5.4. By Application

14. Europe Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. Germany
      • 14.4.1.2. France
      • 14.4.1.3. U.K.
      • 14.4.1.4. Italy
      • 14.4.1.5. Spain
      • 14.4.1.6. Russia
      • 14.4.1.7. Rest of Europe
    • 14.4.2. By Type
    • 14.4.3. By Application
    • 14.4.4. By Application
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Material
    • 14.5.3. By Application
    • 14.5.4. By Application

15. Asia Pacific Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. China
      • 15.4.1.2. Japan
      • 15.4.1.3. South Korea
      • 15.4.1.4. India
      • 15.4.1.5. Australia
      • 15.4.1.6. Rest of Asia Pacific
    • 15.4.2. By Type
    • 15.4.3. By Application
    • 15.4.4. By Application
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Material
    • 15.5.3. By Application
    • 15.5.4. By Application

16. Middle East and Africa Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 16.4.1. By Country
      • 16.4.1.1. Saudi Arabia
      • 16.4.1.2. South Africa
      • 16.4.1.3. Israel
      • 16.4.1.4. UAE
      • 16.4.1.5. Rest of Middle East and Africa
    • 16.4.2. By Type
    • 16.4.3. By Application
    • 16.4.4. By Application
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Material
    • 16.5.3. By Application
    • 16.5.4. By Application

17. Key Countries Microneedle Drug Delivery Systems Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
    • 17.1.1. Market Value Proportion Analysis, By Key Countries
    • 17.1.2. Global Vs. Country Growth Comparison
  • 17.2. US Microneedle Drug Delivery Systems Market Analysis
    • 17.2.1. Value Proportion Analysis by Market Taxonomy
    • 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.2.2.1. By Type
      • 17.2.2.2. By Application
      • 17.2.2.3. By Application
  • 17.3. Canada Microneedle Drug Delivery Systems Market Analysis
    • 17.3.1. Value Proportion Analysis by Market Taxonomy
    • 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.3.2.1. By Material
      • 17.3.2.2. By Application
      • 17.3.2.3. By Application
  • 17.4. Mexico Microneedle Drug Delivery Systems Market Analysis
    • 17.4.1. Value Proportion Analysis by Market Taxonomy
    • 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.4.2.1. By Type
      • 17.4.2.2. By Application
      • 17.4.2.3. By Application
  • 17.5. Brazil Microneedle Drug Delivery Systems Market Analysis
    • 17.5.1. Value Proportion Analysis by Market Taxonomy
    • 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.5.2.1. By Material
      • 17.5.2.2. By Application
      • 17.5.2.3. By Application
  • 17.6. Germany Microneedle Drug Delivery Systems Market Analysis
    • 17.6.1. Value Proportion Analysis by Market Taxonomy
    • 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.6.2.1. By Type
      • 17.6.2.2. By Application
      • 17.6.2.3. By Application
  • 17.7. France Microneedle Drug Delivery Systems Market Analysis
    • 17.7.1. Value Proportion Analysis by Market Taxonomy
    • 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.7.2.1. By Type
      • 17.7.2.2. By Application
      • 17.7.2.3. By Application
  • 17.8. Italy Microneedle Drug Delivery Systems Market Analysis
    • 17.8.1. Value Proportion Analysis by Market Taxonomy
    • 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.8.2.1. By Type
      • 17.8.2.2. By Application
      • 17.8.2.3. By Application
  • 17.9. India Microneedle Drug Delivery Systems Market Analysis
    • 17.9.1. Value Proportion Analysis by Market Taxonomy
    • 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.9.2.1. By Type
      • 17.9.2.2. By Application
      • 17.9.2.3. By Application
  • 17.10. UK Microneedle Drug Delivery Systems Market Analysis
    • 17.10.1. Value Proportion Analysis by Market Taxonomy
    • 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.10.2.1. By Material
      • 17.10.2.2. By Application
      • 17.10.2.3. By Application
  • 17.11. Australia Microneedle Drug Delivery Systems Market Analysis
    • 17.11.1. Value Proportion Analysis by Market Taxonomy
    • 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.11.2.1. By Type
      • 17.11.2.2. By Application
      • 17.11.2.3. By Application
  • 17.12. China Microneedle Drug Delivery Systems Market Analysis
    • 17.12.1. Value Proportion Analysis by Market Taxonomy
    • 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.12.2.1. By Type
      • 17.12.2.2. By Application
      • 17.12.2.3. By Application
  • 17.13. Japan Microneedle Drug Delivery Systems Market Analysis
    • 17.13.1. Value Proportion Analysis by Market Taxonomy
    • 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.13.2.1. By Type
      • 17.13.2.2. By Application
      • 17.13.2.3. By Application
  • 17.14. South Korea Microneedle Drug Delivery Systems Market Analysis
    • 17.14.1. Value Proportion Analysis by Market Taxonomy
    • 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.14.2.1. By Type
      • 17.14.2.2. By Application
      • 17.14.2.3. By Application
  • 17.15. Israel Microneedle Drug Delivery Systems Market Analysis
    • 17.15.1. Value Proportion Analysis by Market Taxonomy
    • 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.15.2.1. By Type
      • 17.15.2.2. By Application
      • 17.15.2.3. By Application
  • 17.16. South Africa Microneedle Drug Delivery Systems Market Analysis
    • 17.16.1. Value Proportion Analysis by Market Taxonomy
    • 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.16.2.1. By Type
      • 17.16.2.2. By Application
      • 17.16.2.3. By Application
  • 17.17. UAE Microneedle Drug Delivery Systems Market Analysis
    • 17.17.1. Value Proportion Analysis by Market Taxonomy
    • 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.17.2.1. By Type
      • 17.17.2.2. By Application
      • 17.17.2.3. By Application
  • 17.18. Spain Microneedle Drug Delivery Systems Market Analysis
    • 17.18.1. Value Proportion Analysis by Market Taxonomy
    • 17.18.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.18.2.1. By Type
      • 17.18.2.2. By Application
      • 17.18.2.3. By Application
  • 17.19. Russia Microneedle Drug Delivery Systems Market Analysis
    • 17.19.1. Value Proportion Analysis by Market Taxonomy
    • 17.19.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.19.2.1. By Type
      • 17.19.2.2. By Application
      • 17.19.2.3. By Application
  • 17.20. Saudi Arabia Microneedle Drug Delivery Systems Market Analysis
    • 17.20.1. Value Proportion Analysis by Market Taxonomy
    • 17.20.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2033
      • 17.20.2.1. By Type
      • 17.20.2.2. By Application
      • 17.20.2.3. By Application
  • 17.21. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Concentration
  • 18.3. Market Share Analysis of Top Players
  • 18.4. Market Presence Analysis
    • 18.4.1. By Regional footprint of Players
    • 18.4.2. Product footprint by Players

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Competition Benchmarking
  • 19.3. Competition Deep Dive
    • 19.3.1. Raphas Co. Ltd.
      • 19.3.1.1. Overview
      • 19.3.1.2. Product Portfolio
      • 19.3.1.3. Sales Footprint
      • 19.3.1.4. Strategy Overview
    • 19.3.2. Becton Dickinson and Company
      • 19.3.2.1. Overview
      • 19.3.2.2. Product Portfolio
      • 19.3.2.3. Sales Footprint
      • 19.3.2.4. Strategy Overview
    • 19.3.3. NanoPass Technologies Limited
      • 19.3.3.1. Overview
      • 19.3.3.2. Product Portfolio
      • 19.3.3.3. Sales Footprint
      • 19.3.3.4. Strategy Overview
    • 19.3.4. 3M
      • 19.3.4.1. Overview
      • 19.3.4.2. Product Portfolio
      • 19.3.4.3. Sales Footprint
      • 19.3.4.4. Strategy Overview
    • 19.3.5. Zosano Pharma Corporation
      • 19.3.5.1. Overview
      • 19.3.5.2. Product Portfolio
      • 19.3.5.3. Sales Footprint
      • 19.3.5.4. Strategy Overview
    • 19.3.6. Corium International Inc.
      • 19.3.6.1. Overview
      • 19.3.6.2. Product Portfolio
      • 19.3.6.3. Sales Footprint
      • 19.3.6.4. Strategy Overview
    • 19.3.7. Valeritas Inc.
      • 19.3.7.1. Overview
      • 19.3.7.2. Product Portfolio
      • 19.3.7.3. Sales Footprint
      • 19.3.7.4. Strategy Overview
    • 19.3.8. Nitto Denko Corporation
      • 19.3.8.1. Overview
      • 19.3.8.2. Product Portfolio
      • 19.3.8.3. Sales Footprint
      • 19.3.8.4. Strategy Overview
    • 19.3.9. Microdermics Inc.
      • 19.3.9.1. Overview
      • 19.3.9.2. Product Portfolio
      • 19.3.9.3. Sales Footprint
      • 19.3.9.4. Strategy Overview
    • 19.3.10. TheraJect Inc.
      • 19.3.10.1. Overview
      • 19.3.10.2. Product Portfolio
      • 19.3.10.3. Sales Footprint
      • 19.3.10.4. Strategy Overview
    • 19.3.11. Vaxxas Pty Ltd.
      • 19.3.11.1. Overview
      • 19.3.11.2. Product Portfolio
      • 19.3.11.3. Sales Footprint
      • 19.3.11.4. Strategy Overview
    • 19.3.12. Endoderma Ltd.
      • 19.3.12.1. Overview
      • 19.3.12.2. Product Portfolio
      • 19.3.12.3. Sales Footprint
      • 19.3.12.4. Strategy Overview
    • 19.3.13. QuadMedicine
      • 19.3.13.1. Overview
      • 19.3.13.2. Product Portfolio
      • 19.3.13.3. Sales Footprint
      • 19.3.13.4. Strategy Overview
    • 19.3.14. SNvia Co. Ltd.
      • 19.3.14.1. Overview
      • 19.3.14.2. Product Portfolio
      • 19.3.14.3. Sales Footprint
      • 19.3.14.4. Strategy Overview
    • 19.3.15. Small Lab
      • 19.3.15.1. Overview
      • 19.3.15.2. Product Portfolio
      • 19.3.15.3. Sales Footprint
      • 19.3.15.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology